These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 29064815

  • 1. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V, Soloviov A, Olefir A.
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [Abstract] [Full Text] [Related]

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF.
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [Abstract] [Full Text] [Related]

  • 3. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S, Woliyi A, Woldemichael K, Tushune K, Duchateau L, Degroote A, Vancauwenberghe R, Bracke N, De Spiegeleer B.
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [Abstract] [Full Text] [Related]

  • 4. [securPharm e. V. - a protective shield against falsified medicines].
    Bergen M, Hoferichter R.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1255-1260. PubMed ID: 28929207
    [Abstract] [Full Text] [Related]

  • 5. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
    Streit R.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1203-1207. PubMed ID: 28936679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Task force for falsified medicines].
    Weber G.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1240-1244. PubMed ID: 28905078
    [Abstract] [Full Text] [Related]

  • 8. [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
    Wittstock M, Paeschke N.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1196-1202. PubMed ID: 28980029
    [Abstract] [Full Text] [Related]

  • 9. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C, Pape E, Scala-Bertola J, Tréchot P, Maincent P, Gibaja V, Gambier N.
    Therapie; 2015 Nov; 70(5):455-64. PubMed ID: 26071144
    [Abstract] [Full Text] [Related]

  • 10. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL, Doyle C, Halliwell-Ewen M, Lambert G.
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [Abstract] [Full Text] [Related]

  • 11. [Falsified pharmaceutical products : Legislative measures in the European Union and in Germany].
    Sträter B.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1188-1195. PubMed ID: 28929177
    [Abstract] [Full Text] [Related]

  • 12. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
    Wanko R, Unkelbach U.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172
    [Abstract] [Full Text] [Related]

  • 13. Regulatory Capture in Pharmaceutical Policy Making: The Case of National Medicine Agencies Related to the EU Falsified Medicines Directive.
    Borup R, Traulsen JM, Kaae S.
    Pharmaceut Med; 2019 Jun; 33(3):199-207. PubMed ID: 31933284
    [Abstract] [Full Text] [Related]

  • 14. Stopping murder by medicine: introducing the Model Law on Medicine Crime.
    Attaran A.
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):127-132. PubMed ID: 25897071
    [Abstract] [Full Text] [Related]

  • 15. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
    't Hoen E, Pascual F.
    J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
    [Abstract] [Full Text] [Related]

  • 16. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.
    Olliaro E, Olliaro P, Ho CWL, Ravinetto R.
    Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.